Literature DB >> 16377442

Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.

Marcus W Brazier1, Victoria Lewis, Giuseppe D Ciccotosto, Genevieve M Klug, Victoria A Lawson, Roberto Cappai, James W Ironside, Colin L Masters, Andrew F Hill, Anthony R White, Steven Collins.   

Abstract

To assess whether heightened oxidative stress plays an early and primary pathogenic role in transmissible spongiform encephalopathies (TSE), we undertook detailed correlative studies using a mouse-adapted model of human disease. The spatio-temporal evolution of the abnormal, protease-resistant isoform of the prion protein (PrP(res)) and neuropathological changes were correlated with the occurrence and type of oxidative stress. Heightened oxidative stress was demonstrated, but restricted to elevated levels of free aldehydic breakdown products of lipid peroxidation, affecting all brain regions to varying extents. The increase in lipid peroxidation was highest over the mid-incubation period, with the onset showing close temporal and general topographical concordance with the first detection of PrP(res) with both pre-empting the typical neuropathological changes of spongiform change, gliosis and neuronal loss. Further, prion propagation over the disease course was assessed using murine bioassay. This revealed that the initial rapid increase in infectivity titres was contemporaneous with the abrupt onset and maximisation of lipid peroxidation. The present results are an important extension to previous studies, showing that heightened oxidative stress in the form of lipid peroxidation is likely to constitute an early primary pathogenic event in TSE, associated temporally with the integral disease processes of prion propagation and PrP(res) formation, and consistent with causal links between these events and subsequent typical neuropathological changes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377442     DOI: 10.1016/j.brainresbull.2005.09.010

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  29 in total

1.  Near-infrared fluorescence imaging of apoptotic neuronal cell death in a live animal model of prion disease.

Authors:  Victoria A Lawson; Cathryn L Haigh; Blaine Roberts; Vijaya B Kenche; Helen M J Klemm; Colin L Masters; Steven J Collins; Kevin J Barnham; Simon C Drew
Journal:  ACS Chem Neurosci       Date:  2010-09-30       Impact factor: 4.418

Review 2.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

3.  MEK1 transduces the prion protein N2 fragment antioxidant effects.

Authors:  C L Haigh; A R McGlade; S J Collins
Journal:  Cell Mol Life Sci       Date:  2014-11-13       Impact factor: 9.261

4.  Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain.

Authors:  Martin P Boland; Claire R Hatty; Frances Separovic; Andrew F Hill; Deborah J Tew; Kevin J Barnham; Cathryn L Haigh; Michael James; Colin L Masters; Steven J Collins
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

5.  The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.

Authors:  Helen M J Klemm; Jeremy M Welton; Colin L Masters; Genevieve M Klug; Alison Boyd; Andrew F Hill; Steven J Collins; Victoria A Lawson
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

6.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

7.  Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.

Authors:  Christopher F Harrison; Victoria A Lawson; Bradley M Coleman; Yong-Sun Kim; Colin L Masters; Roberto Cappai; Kevin J Barnham; Andrew F Hill
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

8.  PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity.

Authors:  Simote T Foliaki; Victoria Lewis; Abu M T Islam; Matteo Senesi; David I Finkelstein; Laura J Ellett; Victoria A Lawson; Paul A Adlard; Blaine R Roberts; Steven J Collins
Journal:  Biophys J       Date:  2020-06-10       Impact factor: 4.033

9.  Unaltered prion protein expression in Alzheimer disease patients.

Authors:  Eri Saijo; Stephen W Scheff; Glenn C Telling
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

10.  Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.

Authors:  Victoria A Lawson; Brooke Lumicisi; Jeremy Welton; Dorothy Machalek; Katrina Gouramanis; Helen M Klemm; James D Stewart; Colin L Masters; David E Hoke; Steven J Collins; Andrew F Hill
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.